Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Tax Provision
Shin Nippon Biomedical Laboratories Ltd
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Tax Provision
-¥1.6B
|
CAGR 3-Years
-98%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
CMIC Holdings Co Ltd
TSE:2309
|
Tax Provision
-¥3.4B
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-5%
|
|
Medinet Co Ltd
TSE:2370
|
Tax Provision
-¥3.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
6%
|
|
CellSource Co Ltd
TSE:4880
|
Tax Provision
-¥316.5m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Tax Provision
-¥396.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
8%
|
CAGR 10-Years
-3%
|
|
WDB coco Co Ltd
TSE:7079
|
Tax Provision
-¥344.1m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Tax Provision?
Tax Provision
-1.6B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Tax Provision amounts to -1.6B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Tax Provision growth rate?
Tax Provision CAGR 10Y
-5%
Over the last year, the Tax Provision growth was -4%. The average annual Tax Provision growth rates for Shin Nippon Biomedical Laboratories Ltd have been -98% over the past three years , -4% over the past five years , and -5% over the past ten years .